Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912261732> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2912261732 abstract "The process of drug discovery is at the interface of chemistry and biology and this work primarily focuses on the development of therapeutically important metabolicmodulators to combat cancer. Exclusive feature of the cancer cells include prominent metabolic imbalances that is preeminently aligned with the hallmarks of cancer. TheWarburg phenotype is a characteristic feature of the cancer cells that allows them a functional redundancy to enhance resistance towards apoptosis. Tumor cells undergoglycolysis for ATP generation rather than utilizing TCA cycle and finally produce lactate in presence of lactate dehydrogenase A (LDH-A) that interconvert pyruvate tolactate and is seen to be responsible for aggressive cancer outcomes. Therefore, LDH-A might be considered as a potential target in the arena of cancer therapeutics as blocking this enzyme would shut down energy supply and associated anabolic reactions. With this background information, this study was undertaken for the synthesis,characterization and deciphering the tumoricidal potential of a novel “dual hit” molecule wherein it would compete with NADH and pyruvate to inhibit LDH-A andselectively initiate apoptosis in the cancer cells, without toxic manifestations.Another objective of the dissertation work was based on the concept of co-drug.Novel co-drug was derivatized and its PLGA based nanoparticles was conceived to bedeveloped that would further boost up the potential of the co-drug, highlighting the therapeutic prospectus of the metabolic modulator loaded nanoparticles in the rapidly expanding chapter of cancer therapeutics.It is a well-established fact that two drugs when added in combination at defined doses can inhibit cancer in a synergistic way by changing the characteristic metabolicsignatures of cancer cells. Realizing the potential that derivatized metabolic modulators can destroy the cancer cells via two different routes, their combination at specific calculated doses was envisioned to mutually mitigate the drawbacks of standard chemotherapeutic regimens, concomitantly underlining the prospectus of metabolic modulators in the clinical setting." @default.
- W2912261732 created "2019-02-21" @default.
- W2912261732 creator A5048495207 @default.
- W2912261732 date "2016-01-01" @default.
- W2912261732 modified "2023-09-27" @default.
- W2912261732 title "Synthesis and Nanoformulation of MetabolicModulators: A Strategic Approach towardsCancer Therapy" @default.
- W2912261732 hasPublicationYear "2016" @default.
- W2912261732 type Work @default.
- W2912261732 sameAs 2912261732 @default.
- W2912261732 citedByCount "0" @default.
- W2912261732 crossrefType "dissertation" @default.
- W2912261732 hasAuthorship W2912261732A5048495207 @default.
- W2912261732 hasConcept C109156525 @default.
- W2912261732 hasConcept C121608353 @default.
- W2912261732 hasConcept C181199279 @default.
- W2912261732 hasConcept C185592680 @default.
- W2912261732 hasConcept C190283241 @default.
- W2912261732 hasConcept C20251656 @default.
- W2912261732 hasConcept C502942594 @default.
- W2912261732 hasConcept C54355233 @default.
- W2912261732 hasConcept C55493867 @default.
- W2912261732 hasConcept C86803240 @default.
- W2912261732 hasConcept C96232424 @default.
- W2912261732 hasConceptScore W2912261732C109156525 @default.
- W2912261732 hasConceptScore W2912261732C121608353 @default.
- W2912261732 hasConceptScore W2912261732C181199279 @default.
- W2912261732 hasConceptScore W2912261732C185592680 @default.
- W2912261732 hasConceptScore W2912261732C190283241 @default.
- W2912261732 hasConceptScore W2912261732C20251656 @default.
- W2912261732 hasConceptScore W2912261732C502942594 @default.
- W2912261732 hasConceptScore W2912261732C54355233 @default.
- W2912261732 hasConceptScore W2912261732C55493867 @default.
- W2912261732 hasConceptScore W2912261732C86803240 @default.
- W2912261732 hasConceptScore W2912261732C96232424 @default.
- W2912261732 hasLocation W29122617321 @default.
- W2912261732 hasOpenAccess W2912261732 @default.
- W2912261732 hasPrimaryLocation W29122617321 @default.
- W2912261732 hasRelatedWork W1868339535 @default.
- W2912261732 hasRelatedWork W2003837645 @default.
- W2912261732 hasRelatedWork W2043828993 @default.
- W2912261732 hasRelatedWork W2044105777 @default.
- W2912261732 hasRelatedWork W2059152897 @default.
- W2912261732 hasRelatedWork W2150874608 @default.
- W2912261732 hasRelatedWork W2401080705 @default.
- W2912261732 hasRelatedWork W2803643946 @default.
- W2912261732 hasRelatedWork W2892866758 @default.
- W2912261732 hasRelatedWork W2913150539 @default.
- W2912261732 hasRelatedWork W2950551181 @default.
- W2912261732 hasRelatedWork W2996231268 @default.
- W2912261732 hasRelatedWork W3043371059 @default.
- W2912261732 hasRelatedWork W3135409592 @default.
- W2912261732 hasRelatedWork W3148945253 @default.
- W2912261732 hasRelatedWork W3162292793 @default.
- W2912261732 hasRelatedWork W3163927698 @default.
- W2912261732 hasRelatedWork W3203076698 @default.
- W2912261732 hasRelatedWork W2338321897 @default.
- W2912261732 hasRelatedWork W3026182861 @default.
- W2912261732 isParatext "false" @default.
- W2912261732 isRetracted "false" @default.
- W2912261732 magId "2912261732" @default.
- W2912261732 workType "dissertation" @default.